Koninklijke Philips (PHG) FCF Payout Ratio Growth (3y) (2012 - 2026)
Koninklijke Philips (PHG) FCF Payout Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -24.36% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -15.73% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 47.27% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -478.95% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.49% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | -16.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -470.02% |
| Dec 31, 2025 | -26.94% |
| Jun 30, 2025 | -38.25% |
| Dec 31, 2024 | -26.00% |
| Sep 30, 2024 | 77.21% |
| Jun 30, 2024 | 83.51% |
| Dec 31, 2023 | -26.00% |
| Jun 30, 2023 | -26.01% |
| Dec 31, 2022 | 97.77% |
| Jun 30, 2022 | 34.35% |
| Dec 31, 2021 | 133.56% |
| Sep 30, 2021 | -22.88% |
| Jun 30, 2021 | 24.95% |
| Dec 31, 2020 | 13.75% |
| Sep 30, 2020 | 77.57% |
| Jun 30, 2020 | 97.57% |
| Dec 31, 2019 | 578.03% |
| Sep 30, 2019 | -7.10% |
| Jun 30, 2019 | -33.84% |
| Dec 31, 2018 | -28.03% |